Secular trends of candidemia in a tertiary care hospital

American Journal of Infection Control

Volumn 38, Issue 7, 2010, Pages 546-551

  Sampaio Camargo, Thiago Zinsly ^a   Marra, Alexandre Rodrigues ^a   Silva, Claudia Vallone ^a   Cardoso, Maria Fatima Santos ^a   Martino, Marinês Dalla Valle ^a   Camargo, Luis Fernando Aranha ^a   Correa, Luci ^a  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

antifungal use; Candidemia; hospital acquired infection; mortality

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE;

ADULT; ARTICLE; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA; CANDIDA ALBICANS; CANDIDEMIA; CLINICAL FEATURE; DRUG USE; FUNGUS ISOLATION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; FUNGEMIA; HOSPITALS; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77956194990     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2009.12.012     Document Type: Article

References (28)

1. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in the US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 1980 309-7
2. S.B. Wey, M. Mori, M.A. Pfaller, R.F. Woolson, and R.P. Wenzel Hospital-acquired candidemia: the attributable mortality and excess length of stay Arch Intern Med 148 1988 2642 2645
3. M.D. Zilberberg, A.F. Shorr, and M.H. Kollef Secular trends in candidemia-related hospitalization in the United States, 2000-2005 Infect Control Hosp Epidemiol 29 2008 978 980
4. S.B. Wey, M. Mori, M.A. Pfaller, R.F. Woolson, and R.P. Wenzel Risk factor for hospital-acquired candidemia: a matched case-control study Arch Intern Med 149 1989 2349 2353
5. O. Marchetii, J. Bille, U. Fluckiger, P. Eggimann, C. Ruef, and J. Garbino Epidemiology of candidemia in Swiss tertiary care hospital: secular trends, 1999-2000. The fungal infection network of Switzerland (FUNGINOS) Clin Infect Dis 38 2004 311 320
6. J.K. Chow, Y. Golan, R. Ruthazer, A.W. Karchmer, Y. Carmeli, and D. Lichtenberg Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit Clin Infect Dis 46 2008 1206 1213
7. S.N. Banerjee, T.G. Emori, D.H. Culver, R.P. Gaynes, W.R. Jarvis, and T. Horan Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infection Surveillance System Am J Med 91 1991 86S 89S
8. A.I. Hidron, J.R. Edwards, J. Patel, T. Horan, D.M. Sievert, and D.A. Pollock Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 Infect Control Hosp Epidemiol 29 2008 996 1011
9. M.H. Nguyen, J.E. Peacock Jr., A.J. Morris, D.C. Tanner, M.L. Nguyen, and D.R. Snydman The changing face of candidemia: emergence of non- Candida albicans species and antifungal resistance Am J Med 100 1996 617 623
10. P. Eggimann, J. Garbino, and D. Pitted Epidemiology of Candida species infections in critically ill non-immunosuppressed patients Lancet Infect Dis 3 2003 685 702
11. A.L. Colombo, M. Nucci, B.J. Park, A.S. Nóuer, B. Arthington-Skaggs, and D.A. da Matta Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers J Clin Microbiol 44 2006 2816 2823
12. A.C. Pasqualoto, R.A. Zimerman, S.H. Alves, V.R. Aquino, D. Branco, and D. Wiltgen Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil Infect Control Hosp Epidemiol 29 2008 898 899
13. R.A. Hajjeh, A.N. Sofair, L.H. Harrison, G.M. Lyon, B.A. Arthington-Skaggs, and A.S. Mirza Incidence of blood stream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program J Clin Microbiol 42 2004 1519 1527
14. J.K. Chow, Y. Golan, R. Ruthazer, A.W. Karchmer, Y. Carmeli, and D.A. Lichtenberg Risk factors for albicans and non-albicans candidemia in the intensive care unit Crit Care Med 36 2008 1993 1998
15. T.C. Horan, M. Andrus, and M. Dudeck CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332
16. WHO Collaborating Center for Drug Statistics Methodology. Anatomical therapeutic chemical (ATC) Classification and defined daily doses (DDD). (Actualization: 2008) Available from: http: // www.whocc.no/atcddd/. Oslo: WHO. Accessed October 6, 2008.
17. Clinical Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 2002. 2nd ed. Document M27-A2. Wayne, PA: Clinical Laboratory Standards Institute; 2002.
18. M.H. Nguyen, C.J. Clancy, V.L. Yu, Y.C. Yu, A.J. Morris, and D.R. Snydman Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia J Infect Dis 177 1998 425 430
19. A.S. Kao, M.E. Brandt, W.R. Pruitt, L.A. Conn, B.A. Perkins, and D.S. Stephens The epidemiology of candidemia in two United States cities: results of a population-based active surveillance Clin Infect Dis 29 1999 1164 1170
20. D.J. Diekema, S.A. Masser, A.B. Brueggemann, S.L. Coffman, G.V. Doern, and L.A. Herwaldt Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study J Clin Microbiol 40 2002 1298 1302
21. H. Richet, P. Roux, C. Des Champs, Y. Esnault, A. Andremont French Candidemia Study Group Candidemia in French hospitals: incidente rates and characteristics. The French Candidemia Study Group Clin Microbiol Infect 8 2002 405 412
22. A. Viudes, J. Pemán, E. Cantón, P. Ubeda, J.L. López-Ribot, and M. Gobernado Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death Eur J Clin Microbiol Infect Dis 21 2002 767 774
23. A.L. Colombo, T. Guimarães, L.R. Silva, L.P. de Almeida Monfardini, A.K. Cunha, and P. Rady Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality Infect Control Hosp Epidemiol 28 2007 570 576
24. C.C. Hung, Y.C. Chen, S.C. Chang, K.T. Luh, and W.C. Hsieh Nosocomial candidemia in a university hospital in Taiwan J Formos Med Assoc 95 1996 19 28
25. J. Garbino, L. Kolarova, P. Rohner, D. Lew, P. Pichna, and D. Pittet Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital Medicine (Baltimore) 81 2002 425 433
26. G. Rennert, R. Kitzes, and H.S. Rennert Epidemiology of candidemia. A nationwide survey in Israel Infection 28 2000 26 29
27. J.D. Sobel Changing epidemiology of invasive candidiasis in intensive care-units-much ado about nothing? Crit Care Med 36 2008 2188 2189
28. M.A. Pfaller, and D.J. Diekema Epidemiology of invasive candidiasis: a persistent public health problem Clin Microbiol Rev 20 2007 133 163